Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP622897.RAcjCSGrte9GtEAtYdYq8HP9-ajwYzhxDnhfdLzqzz94o130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622897.RAcjCSGrte9GtEAtYdYq8HP9-ajwYzhxDnhfdLzqzz94o130_provenance.
• NP1158300.RAWERfIHgYRbWTRb2TuauLwktkfiAW1K7K3XSM34X6OfA130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158300.RAWERfIHgYRbWTRb2TuauLwktkfiAW1K7K3XSM34X6OfA130_provenance.
• NP1158301.RAe7evfCTkYGIEeoUGKDCUWaDOeJ6a2Q8rWdxCZmAHIpg130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158301.RAe7evfCTkYGIEeoUGKDCUWaDOeJ6a2Q8rWdxCZmAHIpg130_provenance.
• NP1158305.RAd-av45SK8vclYnKc27lNvGQZcr_pCWbSqeqRzGW0qDo130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158305.RAd-av45SK8vclYnKc27lNvGQZcr_pCWbSqeqRzGW0qDo130_provenance.
• NP621731.RAg8RmU13seF7QtzSKP8Yl9W0m9MVKFlILCLjfI9UqRYE130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621731.RAg8RmU13seF7QtzSKP8Yl9W0m9MVKFlILCLjfI9UqRYE130_provenance.
• NP624291.RAshaIYK9-Kvi7eN_QftcPEgRjAc9Q8itZG3NNZRc4NGE130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624291.RAshaIYK9-Kvi7eN_QftcPEgRjAc9Q8itZG3NNZRc4NGE130_provenance.
• NP1158302.RAmRR_Z3mxVmyrMvbH7c3BWqFxvR7BiJn_kdT0MUDtyX0130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158302.RAmRR_Z3mxVmyrMvbH7c3BWqFxvR7BiJn_kdT0MUDtyX0130_provenance.
• NP1158303.RAkJg3hvtLpvKj-O6Lm51iwDaTIkjDpU7LgK60UcYMGos130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158303.RAkJg3hvtLpvKj-O6Lm51iwDaTIkjDpU7LgK60UcYMGos130_provenance.
• NP1158307.RAp9OpriYHJDGIqamKYcVbAoft9JTmup0ZMZPNPqoTI3A130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158307.RAp9OpriYHJDGIqamKYcVbAoft9JTmup0ZMZPNPqoTI3A130_provenance.
• NP621646.RALGIL4tq1f6mSp1VU1KILWhz-2QozuVQnTnxshQTIIQc130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621646.RALGIL4tq1f6mSp1VU1KILWhz-2QozuVQnTnxshQTIIQc130_provenance.
• NP624212.RAPfHhrHH9lQ6nrsYm9Gu-T8f-0P_5IlBLHa8a9lxTt08130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624212.RAPfHhrHH9lQ6nrsYm9Gu-T8f-0P_5IlBLHa8a9lxTt08130_provenance.
• NP625431.RAHvPQhx_pab647CCN6ct7rJTjPy1ICpqs7Sr8Ap4uExo130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625431.RAHvPQhx_pab647CCN6ct7rJTjPy1ICpqs7Sr8Ap4uExo130_provenance.
• NP622975.RA42mbEoE6g27WaM8ydaoBO0m6bguNXakIJZz3jrAoCtU130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622975.RA42mbEoE6g27WaM8ydaoBO0m6bguNXakIJZz3jrAoCtU130_provenance.
• NP625352.RA34jXPAVQP7kBMCBvpUsnTAn8zn9MP7w5sdBV_uFoR9k130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625352.RA34jXPAVQP7kBMCBvpUsnTAn8zn9MP7w5sdBV_uFoR9k130_provenance.
• NP1158298.RAGta8CXBzuKonjaGRJz0kuaVeURAmiAJtaQLCCoGTWgg130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158298.RAGta8CXBzuKonjaGRJz0kuaVeURAmiAJtaQLCCoGTWgg130_provenance.
• NP1158304.RA7iykSM-zrQ2fB4yi0W7fqS3CHik-vN1B2o6wBtqRikc130_assertion description "[Here, we investigated whether PSMA serves as a novel regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling by employing PSMA knockdown model and PI3K pharmacological inhibitor (LY294002) in LNCaP prostate cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158304.RA7iykSM-zrQ2fB4yi0W7fqS3CHik-vN1B2o6wBtqRikc130_provenance.